Back to Search Start Over

Association between blood pressure levels and cognitive impairment in older women: a prospective analysis of the Women's Health Initiative Memory Study

Authors :
Longjian Liu
Kathleen M Hayden, PhD
Nathalie S May, MD
Bernhard Haring, MD
Zuolu Liu, MD
Victor W Henderson, ProfMD
Jiu-Chiuan Chen, MD
Edward J Gracely, PhD
Sylvia Wassertheil-Smoller, ProfPhD
Stephen R Rapp, ProfPhD
Source :
The Lancet. Healthy Longevity, Vol 3, Iss 1, Pp e42-e53 (2022)
Publication Year :
2022
Publisher :
Elsevier, 2022.

Abstract

Summary: Background: Whether blood pressure (BP), and at what level of controlled BP, reduces risk of cognitive impairment remains uncertain. We investigated the association of BP and hypertension treatment status with mild cognitive impairment and dementia in older women. Methods: We prospectively analysed a sample of 7207 community-dwelling women aged 65–79 years participating in the Women's Health Initiative Memory Study (WHIMS). Participants were recruited between May 28, 1996, and Dec 13, 1999, at 39 US clinical centres, and they were followed up until Dec 31, 2019. Cognitive function was assessed annually. Mild cognitive impairment and probable dementia were defined through a centralised adjudication process. BP was measured by trained and certified staff at baseline. Pulse pressure (PP) was calculated as systolic BP (SBP) minus diastolic BP. Hypertension was defined using the American Heart Association 2017 Guideline for High BP in Adults. Outcomes were (1) mild cognitive impairment, (2) probable dementia, and (3) cognitive loss (the combined endpoint of either mild cognitive impairment or probable dementia, or both). We estimated hazard ratios (HRs) to assess the association between hypertension, SBP, and PP with the risk of study outcomes using Cox proportional hazards regression models, with adjustment for key covariates. Findings: During a median follow-up of 9 years (IQR 6–15), 1132 (15·7%) participants were classified as mild cognitive impairment, 739 (10·3%) as probable dementia, and 1533 (21·3%) as cognitive loss. The incidence rates per 1000 person-years were 15·3 cases (95% CI 14·4–16·2) for mild cognitive impairment, 9·7 cases (9·0–10·4) for probable dementia, and 20·3 (19·3–21·3) for cognitive loss. Elevated SBP and PP were significantly associated with increased risk of mild cognitive impairment and cognitive loss (test for trends across SBP and PP strata, p

Subjects

Subjects :
Geriatrics
RC952-954.6
Medicine

Details

Language :
English
ISSN :
26667568
Volume :
3
Issue :
1
Database :
Directory of Open Access Journals
Journal :
The Lancet. Healthy Longevity
Publication Type :
Academic Journal
Accession number :
edsdoj.9d17612208bd49e19b9f3e3995680987
Document Type :
article
Full Text :
https://doi.org/10.1016/S2666-7568(21)00283-X